COMPARATIVE EFFECTIVENESS RESEARCH DAILY NEWSFEED Trademark

Trademark Overview

On Wednesday, September 18, 2013, a trademark application was filed for COMPARATIVE EFFECTIVENESS RESEARCH DAILY NEWSFEED with the United States Patent and Trademark Office. The USPTO has given the COMPARATIVE EFFECTIVENESS RESEARCH DAILY NEWSFEED trademark a serial number of 86068296. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 7, 2025. This trademark is owned by National Pharmaceutical Council, Inc.. The COMPARATIVE EFFECTIVENESS RESEARCH DAILY NEWSFEED trademark is filed in the Education & Entertainment Services category with the following description:

On-line non-downloadable electronic newsletters delivered by e-mail in the fields of evidence-based medicine, comparative effectiveness research, health and productivity issues, value-based insurance design, and other related research of importance to the pharmaceutical industry
comparative effectiveness research daily newsfeed

General Information

Serial Number86068296
Word MarkCOMPARATIVE EFFECTIVENESS RESEARCH DAILY NEWSFEED
Filing DateWednesday, September 18, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 7, 2025
Registration Number4590496
Registration DateTuesday, August 19, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesOn-line non-downloadable electronic newsletters delivered by e-mail in the fields of evidence-based medicine, comparative effectiveness research, health and productivity issues, value-based insurance design, and other related research of importance to the pharmaceutical industry
Pseudo MarkCOMPARATIVE EFFECTIVENESS RESEARCH DAILY NEWS FEED
NOT AVAILABLE"DAILY NEWSFEED"

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 7, 2025
Primary Code041
First Use Anywhere DateMonday, October 4, 2010
First Use In Commerce DateMonday, October 4, 2010

Trademark Owner History

Party NameNational Pharmaceutical Council, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWashington, DC 20006
Party NameNational Pharmaceutical Council, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20006

Trademark Events

Event DateEvent Description
Thursday, September 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 27, 2013NOTICE OF PSEUDO MARK E-MAILED
Sunday, December 29, 2013ASSIGNED TO EXAMINER
Wednesday, June 25, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, September 21, 2013NEW APPLICATION ENTERED
Thursday, January 2, 2014NON-FINAL ACTION WRITTEN
Thursday, January 2, 2014NON-FINAL ACTION E-MAILED
Thursday, January 2, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 19, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 19, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 20, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 25, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 25, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, June 25, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, June 25, 2014APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Saturday, July 12, 2014ASSIGNED TO LIE
Tuesday, July 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 19, 2014REGISTERED-SUPPLEMENTAL REGISTER
Monday, August 19, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 15, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 20, 2019TEAS SECTION 8 RECEIVED
Thursday, February 6, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, February 5, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, August 19, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, March 7, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, February 6, 2020NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

newsfeed daily research effectiveness comparative based value productivity insurance issues design pharmaceutical industry importance